CIK 0001816736
- Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 851612845
- Phone
- +1 617-674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,877,065
- in 6 filings, $10.0M under 10b5-1 plans
Net −$11,877,065. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-22 | Khara Rahul General Counsel | Option exercise 10b5-1 | +10,000 | $14.69 | $147K | 10,000 |
| 2023-11-22 | Khara Rahul General Counsel | Sale 10b5-1 | −100 | $50.34 | $5K | 9,900 |
| 2023-11-22 | Khara Rahul General Counsel | Sale 10b5-1 | −9,900 | $51.75 | $512K | 0 |
| 2023-11-22 | Khara Rahul General Counsel | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 79,804 | ||
| 2023-11-15 | Khara Rahul General Counsel | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,900 | 89,804 | ||
| 2023-11-14 | Khara Rahul General Counsel | Option exercise 10b5-1 | +4,900 | $14.69 | $72K | 4,900 |
| 2023-11-14 | Khara Rahul General Counsel | Sale 10b5-1 | −4,113 | $50.53 | $208K | 787 |
| 2023-11-14 | Khara Rahul General Counsel | Sale 10b5-1 | −787 | $51.05 | $40K | 0 |
| 2023-11-03 | Khara Rahul General Counsel | Option exercise 10b5-1 | +100 | $14.69 | $1K | 100 |
| 2023-11-03 | Khara Rahul General Counsel | Sale 10b5-1 | −100 | $50.00 | $5K | 0 |
| 2023-11-03 | Khara Rahul General Counsel | Option exercise · Stock Option (Right to Buy) 10b5-1 | −100 | 94,704 | ||
| 2023-09-16 | Atlas Venture Fund X, L.P. 10% owner | Sale | −2,115 | $53.22 | $113K | 1,593,785 |
| 2023-09-15 | Atlas Venture Fund X, L.P. 10% owner | Sale | −260,894 | $53.16 | $13.9M | 1,595,900 |
| 2023-09-14 | Atlas Venture Fund X, L.P. 10% owner | Sale | −94,440 | $53.05 | $5.0M | 1,856,794 |
| 2023-09-11 | Bryce Joanne Chief Financial Officer | Option exercise | +2,500 | $9.86 | $25K | 3,760 |
| 2023-09-11 | Bryce Joanne Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −2,500 | 76,745 | ||
| 2023-09-01 | Bryce Joanne Chief Financial Officer | Option exercise 10b5-1 | +1,000 | $2.65 | $3K | 2,260 |
| 2023-09-01 | Bryce Joanne Chief Financial Officer | Sale 10b5-1 | −1,000 | $52.99 | $53K | 1,260 |
| 2023-09-01 | Bryce Joanne Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,000 | 3,753 | ||
| 2023-08-21 | Savage William Jacob Chief Medical Officer | Option exercise | +3,000 | $2.65 | $8K | 3,000 |
Page 28 of 32 · 639 trades